We demonstrated that the rhENPP1-Fc protein replacement is effective for inhibiting proliferation associated with the loss of ENPP1 in human induced pluripotent stem cell (hiPSC)-derived VSMCs and for preventing intimal hyperplasia in an animal model of GACI. The gene discussed is ENPP1; the disease is arterial calcification, generalized, of infancy, 1.